gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Global Nucleic Acid Testing Market, By Product Type (Nucleic Acid Test Kits {Polymerase chain reaction (PCR), Transcription-mediated amplification (TMA), Ligase chain reaction (LCR), and Whole genome sequencing} and Consumables, By End User (Hospitals, Pathology laboratories, Research Institutes and Clinics), and Geography - Opportunities & Forecast, 2018-2025

Get Free 20% Customization in this Report


Report Code : HM09A-00-0818 Published Date: August-2018 Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


The global nucleic acid testing market was valued at USD 2,478.0 million in 2017 and is projected to reach USD 4,154.8 million by the end of 2025, growing at a CAGR of 6.8% during 2018–2025.

Figure 1: Global Nucleic Acid Testing Market Revenue, 2018–2025 (USD Million)
 
Source: GMI Research


The key factors bolstering the market growth are growing awareness and rising molecular diagnosis, improving diagnosis rate in developing regions, advancement in technology and shift from curative healthcare to preventive healthcare across the globe.

Based on the product type, polymerase chain reaction segment is anticipated to lead the market during 2018–2025

Polymerase chain reaction segment is expected to hold the maximum market share of about 40% during the forecast period due to operational simplicity and high efficiency. On the other hand, ligase chain reaction segment is projected to exhibit the highest growth rate due to a number of factors, including the expansion of sequencing into new applications in the clinical and applied market segments.

Based on end user, research institutes dominate the market due to extensive research and development activities and lack of molecular diagnostic labs in developing countries, such as China, India, Brazil, etc. The end-user segment includes hospitals, pathology laboratories, research institutes and clinics. Research Institutes’ segment is expected to grow at an estimated CAGR of 7.0% rate during the forecast period, owing to, rising demand for whole-genome sequencing as preventive care diagnosis grows rapidly. Also, the significant rise in demand for molecular testing for the cancer diagnosis, infectious disease, forensic and other applications are predicted to aid the market growth in the coming years.

Players, such as Abbot Laboratories, F. Hoffmann-La Roche Ltd. and Becton, Dickinson and Company are investing a lot in the research & development activities. The major companies are focusing on product launches for keeping leadership in the global nucleic acid testing market. For instance, around more than hundreds of products are in clinical pipelines for nucleic acid testing kits across the globe.                                                                                                          

Figure 2: Global Nucleic Acid Testing Market Revenue, by Region, 2017

Source: GMI Research

North America held the largest share in the global nucleic acid testing market in 2017 owing to the well-developed healthcare system, high disposable income, and favorable reimbursement policies. However, the fastest growth rate is expected to be exhibited by Asia-Pacific during the forecast period owing to increasing adoption of preventive diagnosis care, surging demand for blood transfusion, and government initiatives to implement nucleic acid testing in the public health services.

Various notable players operating in the market include, Abbott Laboratories, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Merck KGaA, Becton, Dickinson and Company, among others.

The global nucleic acid testing market has been segmented on the basis of product type, end use and key geographies. Based on the product type, the market comprises of polymerase chain reaction (PCR), transcription-mediated amplification (TMA), ligase chain reaction (LCR), and whole genome sequencing. The end use areas include hospitals, pathology laboratories, research institutes and clinics.

The research report provides in-depth analysis of the global nucleic acid testing market, based on product type, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for nucleic acid testing market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.


Key questions answered in this research report:
1-    At what pace is nucleic acid testing market growing, globally? What will be the growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the nucleic acid testing market?
4-    What are the various application areas and how they are poised to grow?

 1. Executive Summary 


2. Introduction            
        2.1. Study Objectives        
        2.2. Market Definition        
                2.2.1. Market Covered    
                2.2.2. Geographical Coverage    
                2.2.3. Study Years & Currency    
        2.3. Market Stakeholders        
        2.4. Key Questions this Study will Answer        
        2.5. GMI Research’s Approach & Methodology   
 
3. Global Nucleic Acid Testing Market - Overview            
        3.1. Introduction         `
        3.2. Market Segmentation        
        3.3. Value Chain Analysis        
        3.4. Drivers        
        3.5. Restraints        
        3.6. Trends      
 
4. Global Nucleic Acid Testing Market Revenue Forecast till 2025     

5. Global Nucleic Acid Testing Market by Product Type Revenue Forecast till 2025            
        5.1. Nucleic Acid test Kits
                5.1.1. Transcription-mediated amplification (TMA)
                5.1.2. Polymerase chain reaction (PCR)
                5.1.3. Ligase chain reaction (LCR)
                5.1.4. Whole genome sequencing
         5.2. Consumables
 
6. Global Nucleic Acid Testing Market by Indication Revenue Forecast till 2025            
        6.1. Infectious diseases
        6.2. Cancer
        6.3. Forensic Testing
        6.4. Others
 
7. Global Nucleic Acid Testing Market by End User Revenue Forecast till 2025            
        7.1. Hospitals
        7.2. Pathology laboratories
        7.3. Research Institutes
        7.4. Clinics
 
8. Global Nucleic Acid Testing Market by Geography Revenue Forecast till 2025
 
        8.1. North America Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.1.1. North America Nucleic Acid Testing Market by Product Type (Option 1: 25% customization)
                                8.1.1.1. Nucleic Acid test Kits
                                                8.1.1.1.1. Transcription-mediated amplification (TMA)
                                                8.1.1.1.2. Polymerase chain reaction (PCR)
                                                8.1.1.1.3. Ligase chain reaction (LCR)
                                                8.1.1.1.4. Whole genome sequencing
                                8.1.1.2. Consumables
                8.1.2. North America Nucleic Acid Testing Market by Indication    
                                8.1.2.1. Infectious diseases
                                8.1.2.2. Cancer
                                8.1.2.3. Forensic Testing
                                8.1.2.4. Others
 
                8.1.3. North America Nucleic Acid Testing Market by End User    
                                8.1.3.1. Hospitals
                                8.1.3.2. Pathology laboratories
                                8.1.3.3. Research Institutes
                                8.1.3.4. Clinics 
        8.2. Europe Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.2.1. Europe Nucleic Acid Testing Market by Product Type (Option 2: 25% customization)
                                8.2.1.1. Nucleic Acid test Kits
                                                8.2.1.1.1. Transcription-mediated amplification (TMA)
                                                8.2.1.1.2. Polymerase chain reaction (PCR)
                                                8.2.1.1.3. Ligase chain reaction (LCR)
                                                8.2.1.1.4. Whole genome sequencing
                                8.2.1.2. Consumables
                8.2.2. Europe Nucleic Acid Testing Market by Indication    
                                8.2.2.1. Infectious diseases
                                8.2.2.2. Cancer
                                8.2.2.3. Forensic Testing
                                8.2.2.4. Others
 
                8.2.3. Europe Nucleic Acid Testing Market by End User    
                                8.2.3.1. Hospitals
                                8.2.3.2. Pathology laboratories
                                8.2.3.3. Research Institutes
                                8.2.3.4. Clinics
  
        8.3. Asia-Pacific Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.3.1. Asia-Pacific Nucleic Acid Testing Market by Product Type (Option 3: 25% customization)
                                8.3.1.1. Nucleic Acid test Kits
                                                8.3.1.1.1. Transcription-mediated amplification (TMA)
                                                8.3.1.1.2. Polymerase chain reaction (PCR)
                                                8.3.1.1.3. Ligase chain reaction (LCR)
                                                8.3.1.1.4. Whole genome sequencing
                                8.3.1.2. Consumables
                8.3.2. Asia-Pacific Nucleic Acid Testing Market by Indication    
                                8.3.2.1. Infectious diseases
                                8.3.2.2. Cancer
                                8.3.2.3. Forensic Testing
                                8.3.2.4. Others
 
                8.3.3. Asia-Pacific Nucleic Acid Testing Market by End User    
                                8.3.3.1. Hospitals
                                8.3.3.2. Pathology laboratories
                                8.3.3.3. Research Institutes
                                8.3.3.4. Clinics
  
        8.4. Rest of the World Nucleic Acid Testing Market Revenue Forecast till 2025        
                8.4.1. Rest of the World Nucleic Acid Testing Market by Product Type (Option 4: 25%                                                    customization)
                                8.4.1.1. Nucleic Acid test Kits
                                                8.4.1.1.1. Transcription-mediated amplification (TMA)
                                                8.4.1.1.2. Polymerase chain reaction (PCR)
                                                8.4.1.1.3. Ligase chain reaction (LCR)
                                                8.4.1.1.4. Whole genome sequencing
                                8.4.1.2. Consumables
                8.4.2. Rest of the World Nucleic Acid Testing Market by Indication    
                                8.4.2.1. Infectious diseases
                                8.4.2.2. Cancer
                                8.4.2.3. Forensic Testing
                                8.4.2.4. Others
 
                8.4.3. Rest of the World Nucleic Acid Testing Market by End User    
                                8.4.3.1. Hospitals
                                8.4.3.2. Pathology laboratories
                                8.4.3.3. Research Institutes
                                8.4.3.4. Clinics 
 
9. Competitive Landscape            
        9.1. Industry Attractiveness
        9.2. Porter 5 Analysis
        9.3. Major players and their key strategies
        9.4. Company Share Analysis      
 
10. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your                  Choice)
        10.1. Agilent Technologies        
                          10.1.1.1. Company Overview    
                           10.1.1.2. Financials    
                           10.1.1.3. Recent Developments    
        10.2. Danaher Corporation        
                           10.2.1.1. Company Overview    
                          10.2.1.2. Financials    
                          10.2.1.3. Recent Developments    
        10.3. Abbott Laboratories, Inc.    
                          10.3.1.1. Company Overview    
                          10.3.1.2. Financials    
                          10.3.1.3. Recent Developments    
        10.4. Becton, Dickinson and Company        
                          10.4.1.1. Company Overview    
                          10.4.1.2. Financials    
                          10.4.1.3. Recent Developments    
        10.5. Bio-Rad Laboratories Inc.        
                          10.5.1.1. Company Overview    
                          10.5.1.2. Financials    
                          10.5.1.3. Recent Developments    
        10.6. F. Hoffmann-La Roche Ltd.        
                          10.6.1.1. Company Overview    
                          10.6.1.2. Financials    
                          10.6.1.3. Recent Developments    
        10.7. Illumina, Inc.        
                          10.7.1.1. Company Overview    
                          10.7.1.2. Financials    
                          10.7.1.3. Recent Developments    
        10.8. Thermo Fisher Scientific Inc.      
                          10.8.1.1. Company Overview    
                          10.8.1.2. Financials    
                          10.8.1.3. Recent Developments    
        10.9. Qiagen 
                          10.9.1.1. Company Overview    
                          10.9.1.2. Financials    
                          10.9.1.3. Recent Developments
        10.10. Merck KGaA, 
                          10.10.1.1. Company Overview    
                          10.10.1.2. Financials    
                          10.10.1.3. Recent Developments
 
11. About GMI Research